Unique responses of stem cell-derived vascular endothelial and mesenchymal cells to high levels of glucose

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Keats, Emily ^a   Khan, Zia A ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; CASPASE 3; CATALASE; CCAAT ENHANCER BINDING PROTEIN; CD31 ANTIGEN; CD34 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 5; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; FIBRONECTIN; GLUCOSE; GLUTATHIONE PEROXIDASE; HEME OXYGENASE 1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RNA 18S; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR SOX9; VASCULOTROPIN RECEPTOR 2; VON WILLEBRAND FACTOR; PRIMER DNA;

ADIPOCYTE; ADULT; AMINO ACID SEQUENCE; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL GROWTH; CELL ISOLATION; CELL LINEAGE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STROMA CELL; MICROVASCULAR ENDOTHELIAL CELL; MONONUCLEAR CELL; NORMAL HUMAN; OXIDATION REDUCTION STATE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STEM CELL; ANALYSIS OF VARIANCE; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; PATHOPHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION;

ANALYSIS OF VARIANCE; CASPASE 3; CELL DIFFERENTIATION; CELL MOVEMENT; DIABETES COMPLICATIONS; DNA PRIMERS; ENDOTHELIAL CELLS; GLUCOSE; HUMANS; HYPERGLYCEMIA; MESENCHYMAL STEM CELLS; MICROSCOPY, FLUORESCENCE; REAL-TIME POLYMERASE CHAIN REACTION; STEM CELLS;

EID: 84862023342     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0038752     Document Type: Article

References (38)

1. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
2. Khan ZA, Farhangkhoee H, Chakrabarti S, (2006) Towards newer molecular targets for chronic diabetic complications. Curr Vasc Pharmacol 4: 45-57.
3. Engerman R, Bloodworth JM, Nelson S, (1977) Relationship of microvascular disease in diabetes to metabolic control. Diabetes 26: 760-769.
4. Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, et al. (2010) Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care 33: 1090-1096.
5. Ratner RE, (2001) Glycemic control in the prevention of diabetic complications. Clin Cornerstone 4: 24-37.
6. Aronson D, (2008) Hyperglycemia and the pathobiology of diabetic complications. Adv Cardiol 45: 1-16.
7. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
8. Walter DH, Dimmeler S, (2002) Endothelial progenitor cells: regulation and contribution to adult neovascularization. Herz 27: 579-588.
9. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
10. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, et al. (2000) Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105: 1527-1536.
11. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, et al. (1999) Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5: 434-438.
12. Yamashita J, Itoh H, Hirashima M, Ogawa M, Nishikawa S, et al. (2000) Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408: 92-96.
13. Ferreira LS, Gerecht S, Shieh HF, Watson N, Rupnick MA, et al. (2007) Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res 101: 286-294.
14. Melero-Martin JM, De Obaldia ME, Kang SY, Khan ZA, Yuan L, et al. (2008) Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 103: 194-202.
15. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786.
16. Lopez-Holgado N, Alberca M, Sanchez-Guijo F, Villaron E, Almeida J, et al. (2007) Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy 9: 14-22.
17. Capla JM, Grogan RH, Callaghan MJ, Galiano RD, Tepper OM, et al. (2007) Diabetes impairs endothelial progenitor cell-mediated blood vessel formation in response to hypoxia. Plast Reconstr Surg 119: 59-70.
18. Kusuyama T, Omura T, Nishiya D, Enomoto S, Matsumoto R, et al. (2006) Effects of treatment for diabetes mellitus on circulating vascular progenitor cells. J Pharmacol Sci 102: 96-102.
19. Jackson CJ, Garbett PK, Nissen B, Schrieber L, (1990) Binding of human endothelium to Ulex europaeus I-coated Dynabeads: application to the isolation of microvascular endothelium. J Cell Sci 96 (Pt 2): 257-262.
20. Goldstein JL, Ho YK, Basu SK, Brown MS, (1979) Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A 76: 333-337.
21. Khan ZA, Melero-Martin JM, Wu X, Paruchuri S, Boscolo E, et al. (2006) Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 108: 915-921.
22. MacArthur BD, Please CP, Oreffo RO, (2008) Stochasticity and the molecular mechanisms of induced pluripotency. PLoS One 3: e3086.
23. Leung VY, Gao B, Leung KK, Melhado IG, Wynn SL, et al. (2011) SOX9 governs differentiation stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression. PLoS Genet 7: e1002356.
24. Khan ZA, Farhangkhoee H, Mahon JL, Bere L, Gonder JR, et al. (2006) Endothelins: regulators of extracellular matrix protein production in diabetes. Exp Biol Med (Maywood) 231: 1022-1029.
25. Khan ZA, Cukiernik M, Gonder JR, Chakrabarti S, (2004) Oncofetal fibronectin in diabetic retinopathy. Invest Ophthalmol Vis Sci 45: 287-295.
26. Khan ZA, Chakrabarti S, (2003) Endothelins in chronic diabetic complications. Can J Physiol Pharmacol 81: 622-634.
27. Khan ZA, Chakrabarti S, (2006) Therapeutic targeting of endothelial dysfunction in chronic diabetic complications. Recent Pat Cardiovasc Drug Discov 1: 167-175.
28. Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M, (1988) Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J Clin Invest 82: 735-738.
29. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, et al. (2005) Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 45: 1449-1457.
30. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, et al. (2004) Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53: 195-199.
31. Yue WS, Lau KK, Siu CW, Wang M, Yan GH, et al. (2011) Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 10: 113.
32. Yang K, Wang XQ, He YS, Lu L, Chen QJ, et al. (2010) Advanced glycation end products induce chemokine/cytokine production via activation of p38 pathway and inhibit proliferation and migration of bone marrow mesenchymal stem cells. Cardiovasc Diabetol 9: 66.
33. Caplan AI, (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347.
34. Caplan AI, (1991) Mesenchymal stem cells. J Orthop Res 9: 641-650.
35. Prockop DJ, (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
36. Chung SS, Lee JS, Kim M, Ahn BY, Jung HS, et al. (2012) Regulation of Wnt/beta-Catenin Signaling by CCAAT/Enhancer Binding Protein beta During Adipogenesis. Obesity (Silver Spring) 20: 482-487.
37. Muruganandan S, Roman AA, Sinal CJ, (2009) Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci 66: 236-253.
38. Rosen ED, MacDougald OA, (2006) Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7: 885-896.